+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Ginsenoside Rg2

BP0665
52286-74-5
98%
Phytopurify
Ginsenoside Rg2 has therapeutic potential for type 2 diabetic patients, it also may represent a potential neurorestorative treatment strategy for vascular dementia or other ischemic insults, has protective effects against H2O2-induced injury and apoptosis in H9c2 cells. Ginsenoside Rg2 suppresses the hepatic glucose production via AMPK-induced phosphorylation of GSK3β and induction of SHP gene expression, regulates the 5-HT3A receptors that are expressed in Xenopus oocytes, inhibits nicotinic acetylcholine receptor-mediated Na+ influx and channel activity. Ginsenoside Rg2 is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy group at position 6 has been converted to the corresponding alpha-L-rhamnopyranosyl-(12)-beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as an anticoagulant, a plant metabolite and a cardioprotective agent.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0665-20mg 20mg
BP0665-100mg 100mg
BP0665-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

NOS3 GSK3B ACHE BDNF GRIN1 CHAT
NOS3 BCL2 SIRT1 TNF NOS2 MAPK8 PIK3CA NFKB1 AKT1 CASP3 IL6 SOD2 ICAM1

Ginsenoside Rg2 Related Products

Product drug property prediction parameters

  • 218.9900

  • 3.1018

  • 3.1014

  • .0429

  • .6108

  • .2027

  • Low

  • 67.0258

  • 6.0007

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • No